vs

Side-by-side financial comparison of UiPath, Inc. (PATH) and Sotera Health Co (SHC). Click either name above to swap in a different company.

UiPath, Inc. is the larger business by last-quarter revenue ($411.1M vs $303.4M, roughly 1.4× Sotera Health Co). UiPath, Inc. runs the higher net margin — 48.4% vs 11.5%, a 36.9% gap on every dollar of revenue. On growth, UiPath, Inc. posted the faster year-over-year revenue change (15.9% vs 4.6%). Sotera Health Co produced more free cash flow last quarter ($52.4M vs $25.1M). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs 0.7%).

UiPath Inc. is a global software company that develops artificial intelligence (AI) and agentic automation and orchestration software. The company's software enables the building and orchestration of AI agents to automate complex processes and workflows.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

PATH vs SHC — Head-to-Head

Bigger by revenue
PATH
PATH
1.4× larger
PATH
$411.1M
$303.4M
SHC
Growing faster (revenue YoY)
PATH
PATH
+11.4% gap
PATH
15.9%
4.6%
SHC
Higher net margin
PATH
PATH
36.9% more per $
PATH
48.4%
11.5%
SHC
More free cash flow
SHC
SHC
$27.3M more FCF
SHC
$52.4M
$25.1M
PATH
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
0.7%
PATH

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PATH
PATH
SHC
SHC
Revenue
$411.1M
$303.4M
Net Profit
$198.8M
$34.8M
Gross Margin
83.3%
54.7%
Operating Margin
3.2%
23.2%
Net Margin
48.4%
11.5%
Revenue YoY
15.9%
4.6%
Net Profit YoY
1966.2%
182.8%
EPS (diluted)
$0.37
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PATH
PATH
SHC
SHC
Q4 25
$411.1M
$303.4M
Q3 25
$361.7M
$311.3M
Q2 25
$356.6M
$294.3M
Q1 25
$423.6M
$254.5M
Q4 24
$354.7M
$290.2M
Q3 24
$316.3M
$285.5M
Q2 24
$335.1M
$276.6M
Q1 24
$405.3M
$248.2M
Net Profit
PATH
PATH
SHC
SHC
Q4 25
$198.8M
$34.8M
Q3 25
$1.6M
$48.4M
Q2 25
$-22.6M
$8.0M
Q1 25
$51.8M
$-13.3M
Q4 24
$-10.7M
$12.3M
Q3 24
$-86.1M
$17.0M
Q2 24
$-28.7M
$8.8M
Q1 24
$33.9M
$6.3M
Gross Margin
PATH
PATH
SHC
SHC
Q4 25
83.3%
54.7%
Q3 25
82.2%
57.0%
Q2 25
82.1%
56.6%
Q1 25
84.8%
53.2%
Q4 24
82.0%
56.6%
Q3 24
80.0%
55.4%
Q2 24
83.5%
55.2%
Q1 24
86.8%
51.2%
Operating Margin
PATH
PATH
SHC
SHC
Q4 25
3.2%
23.2%
Q3 25
-5.6%
23.4%
Q2 25
-4.6%
6.4%
Q1 25
7.9%
-5.8%
Q4 24
-12.2%
30.0%
Q3 24
-32.7%
28.2%
Q2 24
-14.8%
27.8%
Q1 24
3.7%
21.4%
Net Margin
PATH
PATH
SHC
SHC
Q4 25
48.4%
11.5%
Q3 25
0.4%
15.5%
Q2 25
-6.3%
2.7%
Q1 25
12.2%
-5.2%
Q4 24
-3.0%
4.2%
Q3 24
-27.2%
6.0%
Q2 24
-8.6%
3.2%
Q1 24
8.4%
2.5%
EPS (diluted)
PATH
PATH
SHC
SHC
Q4 25
$0.37
$0.12
Q3 25
$0.00
$0.17
Q2 25
$-0.04
$0.03
Q1 25
$0.09
$-0.05
Q4 24
$-0.02
$0.05
Q3 24
$-0.15
$0.06
Q2 24
$-0.05
$0.03
Q1 24
$0.07
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PATH
PATH
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$1.4B
$344.6M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$1.9B
$606.0M
Total Assets
$2.9B
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PATH
PATH
SHC
SHC
Q4 25
$1.4B
$344.6M
Q3 25
$1.4B
$299.2M
Q2 25
$1.6B
$332.4M
Q1 25
$1.6B
$304.4M
Q4 24
$1.6B
$277.2M
Q3 24
$1.7B
$306.7M
Q2 24
$1.9B
$246.1M
Q1 24
$1.9B
$261.1M
Total Debt
PATH
PATH
SHC
SHC
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.2B
Stockholders' Equity
PATH
PATH
SHC
SHC
Q4 25
$1.9B
$606.0M
Q3 25
$1.7B
$550.5M
Q2 25
$1.7B
$511.3M
Q1 25
$1.8B
$414.1M
Q4 24
$1.7B
$404.9M
Q3 24
$1.8B
$470.2M
Q2 24
$2.0B
$422.8M
Q1 24
$2.0B
$429.4M
Total Assets
PATH
PATH
SHC
SHC
Q4 25
$2.9B
$3.3B
Q3 25
$2.6B
$3.2B
Q2 25
$2.6B
$3.2B
Q1 25
$2.9B
$3.1B
Q4 24
$2.7B
$3.1B
Q3 24
$2.7B
$3.1B
Q2 24
$2.8B
$3.1B
Q1 24
$3.0B
$3.1B
Debt / Equity
PATH
PATH
SHC
SHC
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×
Q2 24
5.26×
Q1 24
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PATH
PATH
SHC
SHC
Operating Cash FlowLast quarter
$28.3M
$103.1M
Free Cash FlowOCF − Capex
$25.1M
$52.4M
FCF MarginFCF / Revenue
6.1%
17.3%
Capex IntensityCapex / Revenue
0.8%
16.7%
Cash ConversionOCF / Net Profit
0.14×
2.96×
TTM Free Cash FlowTrailing 4 quarters
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PATH
PATH
SHC
SHC
Q4 25
$28.3M
$103.1M
Q3 25
$41.6M
$71.2M
Q2 25
$119.0M
$57.4M
Q1 25
$146.1M
$55.5M
Q4 24
$28.1M
$55.7M
Q3 24
$46.4M
$97.5M
Q2 24
$100.0M
$61.3M
Q1 24
$145.6M
$9.7M
Free Cash Flow
PATH
PATH
SHC
SHC
Q4 25
$25.1M
$52.4M
Q3 25
$35.0M
Q2 25
$106.2M
$26.2M
Q1 25
$138.7M
$35.6M
Q4 24
$23.2M
$-10.2M
Q3 24
$45.0M
$61.1M
Q2 24
$98.8M
$19.4M
Q1 24
$141.8M
$-25.2M
FCF Margin
PATH
PATH
SHC
SHC
Q4 25
6.1%
17.3%
Q3 25
11.2%
Q2 25
29.8%
8.9%
Q1 25
32.7%
14.0%
Q4 24
6.5%
-3.5%
Q3 24
14.2%
21.4%
Q2 24
29.5%
7.0%
Q1 24
35.0%
-10.2%
Capex Intensity
PATH
PATH
SHC
SHC
Q4 25
0.8%
16.7%
Q3 25
0.0%
11.6%
Q2 25
3.6%
10.6%
Q1 25
1.7%
7.8%
Q4 24
1.4%
22.7%
Q3 24
0.4%
12.7%
Q2 24
0.4%
15.2%
Q1 24
0.9%
14.1%
Cash Conversion
PATH
PATH
SHC
SHC
Q4 25
0.14×
2.96×
Q3 25
26.25×
1.47×
Q2 25
7.21×
Q1 25
2.82×
Q4 24
4.52×
Q3 24
5.73×
Q2 24
7.00×
Q1 24
4.29×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PATH
PATH

Subscription Services$247.6M60%
License$150.0M36%
Professional Services And Other$13.5M3%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons